Started with fifty410 in 2024 with semaglutide for 3 months but I stoped. I keep gaining weight ! In Sep 2025 I got tired of being in so much pain and being so much over weight I search and search but I went back to the BEST PLACE Fifty410! I order de medium 3 month Suply and it had being the best decision of my life. From my start at 198.8 in Sep 20 to now Feb 8 151 lbs I have 11 pounds to be at goal weight I feel great ! The support is amazing ! I highly recommend it ! Just do it you won’t reject this decision is an amazing company, product, community, support I love it.
Thank you ! Angie Reed
Claim your business profile now and gain access to all features and respond to customer reviews.
Fifty 410 is a modern telehealth platform dedicated to transforming the way people approach weight loss, wellness, and overall health. As a leader in personalized care, we specialize in offering access to GLP-1 medications such as Semaglutide and Tirzepatide, which are prescribed through convenient virtual consultations and shipped directly to our patients’ homes. This seamless, accessible approach to treatment removes the traditional barriers of in-person care, allowing patients to begin their health journeys with ease and confidence.
What sets Fifty 410 apart is our partnership with a certified 503B pharmacy, ensuring that every medication dispensed meets the highest standards for safety, quality, and efficacy. Each treatment plan is tailored to the unique needs of the individual, reinforcing our belief that health is not one-size-fits-all.
While weight loss remains a core focus, Fifty 410 is actively expanding into a broader spectrum of health services. We now offer solutions for both men and women that include hormone optimization, urgent care support, and overall wellness management. Our mission is to simplify the healthcare experience and empower our patients to take control of their health journeys. By delivering trusted, high-quality care directly to the patient, we’re helping people live healthier, more confident lives—on their own terms.See more
